Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Lees

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Canadian Medical Association Journal|June 1, 1981
Reproductive events and family history as risk factors for breast cancer in northern AlbertaP E Burns, A W Lees, M E Hurlburt, et al.
Chest|June 1, 1972
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment casesA W Lees, G W Allan, J Smith, et al.
Lancet (London, England)|October 25, 1975
Probenecid and rifampicin serum levelsR J Fallon, A W Lees, G W Allan, et al.
The American Review of Respiratory Disease|January 1, 1972
Re-treatment of pulmonary tuberculosis with rifampin and ethambutolA W Lees, G W Allan, J Smith, et al.
The American Review of Respiratory Disease|January 1, 1972
Isoniazid and ethambutol in previously untreated patients with pulmonary tuberculosisA W Lees, G W Allan, J Smith, et al.
Tubercle|September 1, 1971
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapyA W Lees, G W Allan, J Smith, et al.
Preventive Medicine|March 1, 1983
Trends in the incidence of cancer of the female breast and reproductive tract in Alberta, 1953 to 1977G B Hill, P E Burns, M Koch, et al.
Progress in Clinical and Biological Research|January 1, 1989
Selective screening for late stage breast cancer using a logistic modelS E McGregor, G B Hill, L L Yuan, et al.
Breast Cancer Research and Treatment|March 1, 1989
Risk factors and 10-year breast cancer survival in northern AlbertaA W Lees, H J Jenkins, C L May, et al.
The Breast Journal|May 1, 2001
Tamoxifen in breast cancer: symptom reportingB J Arnold, C E Cumming, A W Lees, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Canadian Medical Association Journal|June 1, 1981
Reproductive events and family history as risk factors for breast cancer in northern AlbertaP E Burns, A W Lees, M E Hurlburt, et al.
Chest|June 1, 1972
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment casesA W Lees, G W Allan, J Smith, et al.
Lancet (London, England)|October 25, 1975
Probenecid and rifampicin serum levelsR J Fallon, A W Lees, G W Allan, et al.
The American Review of Respiratory Disease|January 1, 1972
Re-treatment of pulmonary tuberculosis with rifampin and ethambutolA W Lees, G W Allan, J Smith, et al.
The American Review of Respiratory Disease|January 1, 1972
Isoniazid and ethambutol in previously untreated patients with pulmonary tuberculosisA W Lees, G W Allan, J Smith, et al.
Tubercle|September 1, 1971
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapyA W Lees, G W Allan, J Smith, et al.
Preventive Medicine|March 1, 1983
Trends in the incidence of cancer of the female breast and reproductive tract in Alberta, 1953 to 1977G B Hill, P E Burns, M Koch, et al.
Progress in Clinical and Biological Research|January 1, 1989
Selective screening for late stage breast cancer using a logistic modelS E McGregor, G B Hill, L L Yuan, et al.
Breast Cancer Research and Treatment|March 1, 1989
Risk factors and 10-year breast cancer survival in northern AlbertaA W Lees, H J Jenkins, C L May, et al.
The Breast Journal|May 1, 2001
Tamoxifen in breast cancer: symptom reportingB J Arnold, C E Cumming, A W Lees, et al.
Pageof 5